Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma

NCT00074178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: etoposide phosphate
DRUG: methotrexate

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]